MacTel Differentiation: It’s the Company You Keep 

Obtaining a diagnosis of macular telangiectasia requires taking the whole picture into consideration, looking for a group of features rather than one definitive sign. 

By Dante J. Pieramici, MD, FASRS

Biosimilars in Retina Care

This expanding category of drugs can make a global impact on retinal disease.

By Ashish Sharma, MD

Optimizing Your Retina Drug Inventory Process 

A practical look at available tools, how they differ, and where practices are leaving cost savings on the table

By Peter A. Karth, MD, MBA, FASRS, FACS

Integrating Photobiomodulation Into Retina Practice

Initial experience sheds light on its potential.

By David A. Eichenbaum, MD

A Comprehensive View With Silverstone RGB

Spotlight on Technology & Technique
The new Silverstone platform from Optos narrows the gap between visualization and structural insight in retinal imaging.

Case Study: Identifying Patients With GA for Complement Inhibition Treatment

Patient selection is critical to optimize our treatment outcomes.

By Jonathan Jonisch, MD, FASRS

Case Study: Early Treatment of Geographic Atrophy

Identifying and treating GA patients early is the most impactful decision a retina specialist can make in managing geographic atrophy.

By Nikolas London, MD